Inhibrx Biosciences, Inc.

Regulation FD Disclosure

Regulation FD Disclosure

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Submission of Matters to a Vote of Security Holders

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Regulation FD Disclosure

Annual Report Scanned (Paper)

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Regulation FD Disclosure

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Regulation FD Disclosure

Regulation FD Disclosure

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Regulation FD Disclosure

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Notice of Effectiveness

Post-effective amendment to a registration statement

Submission of Matters to a Vote of Security Holders

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Annual Report Scanned (Paper)

Post-effective amendment to a registration statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Prospectus Supplement for Primary Offering

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Post-effective amendment filed solely to add exhibits

Prospectus Supplement for Primary Offering

Regulation FD Disclosure

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Letter from the SEC

Correspondence with the SEC

Registration (IPO) statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

No description available

Certification of approval for listing and registration on a national securities exchange

Correspondence with the SEC

No description available

Correspondence with the SEC

Letter from the SEC

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC

Draft registration statement (confidential submission)

Lappe Mark

Kayyem Jon Faiz

MANHARD KIMBERLY

Vuori Kristiina MD

FORSYTH DOUGLAS

Kayyem Jon Faiz

Kayyem Jon Faiz

MANHARD KIMBERLY

MANHARD KIMBERLY

MANHARD KIMBERLY

MANHARD KIMBERLY

MANHARD KIMBERLY

MANHARD KIMBERLY

FORSYTH DOUGLAS

Lappe Mark

MANHARD KIMBERLY

Kayyem Jon Faiz